SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syncom Formulations (India) informs about details of loss of certificate

02 Aug 2022 Evaluate
Syncom Formulations (India) has informed regarding issuance of duplicate share certificates/ Letter of Confirmation due to Loss of Share Certificates under Regulation 39(3) of SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

13.71 0.34 (2.54%)
15-Apr-2026 11:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.40
Dr. Reddys Lab 1219.00
Cipla 1224.55
Zydus Lifesciences 936.00
Lupin 2350.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×